Bharat Tewarie
Chief Executive Officer at ViroCarb, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mario Huesca | M | - |
ViroCarb, Inc.
 ViroCarb, Inc. Pharmaceuticals: MajorHealth Technology Virocarb Inc is a biotechnology company located in Canada that develops drugs for viral infections with critical unmet therapeutic needs. | 12 years |
| Ulf Arne Wiinberg | M | 66 | 8 years | |
| Jan Berger | M | 67 | 5 years | |
| Markus Okumus | M | - |
FORM Life Ventures
 FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | 2 years |
| Pierre Gurdjian | M | 63 | 8 years | |
| Charl van Zyl | M | 57 | 7 years | |
| Raymond Tabibiazar | M | 53 |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Neka Pasquale | F | - |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Jay Wohlgemuth | M | - |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Kirsten Lund Jurgensen | M | 65 | 5 years | |
| Dhavalkumar Patel | M | 63 | 7 years | |
| Nina Fichtl | M | - |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Jean Fleurial | M | 59 | 7 years | |
| Thomas G. Cornwell | M | - |
Webster University
| 34 years |
| Laurent Fischer | M | 60 |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Thomas Zeltner | M | - |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
| Jeffrey Blumberg | M | - |
FORM Life Ventures
FORM Life Ventures Investment ManagersFinance FORM Life (FORM Life ventures) is venture capital firm founded in 2022 by Markus Okumus. FORM Life Ventures is headquartered in Luxembourg. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Viviane Monges | F | 60 | - | |
| Harriet Edelman | F | 68 | 5 years | |
| James E. Hoyes | M | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 9 years |
| Fabrice Enderlin | M | - | 9 years | |
| Elmar Schnee | M | 65 |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 7 years |
| Thomas Fulton Wilson McKillop | M | 81 | 7 years | |
| Gerhard Mayr | M | 78 | 12 years | |
| Mark McDade | M | 69 | 8 years | |
| Sjef de Kimpe | M | - |
University of Utrecht
| 10 years |
| Gary Zieziula | M | 69 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Patrick de van der Schueren | M | - |
University of Utrecht
| 7 years |
| Mohammed Khoso Baluch | M | 66 | 8 years | |
| Drew Young | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Adrianus Johannes Antonius Kas | M | - |
University of Utrecht
| 1 years |
| Gerald Winkels | M | 68 |
University of Utrecht
| 1 years |
| Paris Panayiotopoulos | M | 50 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Dave Jenkins | M | - |
Webster University
| 2 years |
| Michael J. Daniels | M | 77 |
Webster University
| 4 years |
| Maziar Mike Doustdar | M | 54 |
Webster University
| 4 years |
| Thorsten Eickenhorst | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Mathias Locher | M | - |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 4 years |
| Philip A. van Damme | M | 70 |
University of Utrecht
| 3 years |
| Craig Millian | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Rami Levin | M | 55 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Evan Lippman | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Jamie Hawley | M | 63 |
Webster University
| 1 years |
| Antonio Gualberto | M | 59 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Neil Weir | M | - | - | |
| Lilian Haagsman | F | - |
University of Utrecht
| 3 years |
| Alain Bernard | M | 67 | 10 years | |
| Jonathan Zung | M | 59 | 2 years | |
| Duncan McHale | M | 57 | 6 years | |
| Ernesto Aycardi | M | 61 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 1 years |
| Helen Sabzevari | M | 62 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Amy Broidrick | F | 66 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| David Tuck | M | 72 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Berend Scheffers | M | - |
University of Utrecht
| 4 years |
| Pascale Richetta | M | 65 | 4 years | |
| Luigi Marro | M | - |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 2 years |
| George Blackman | M | - | 9 years | |
| Adrianus Christianus Gerardus de Beer | M | 65 |
University of Utrecht
| 2 years |
| Alex Kuta | M | 64 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Thijs Berman | M | 66 |
University of Utrecht
| 4 years |
| Joost Lagendijk | M | 67 |
University of Utrecht
| 4 years |
| G. Douglas Bolen | M | - |
Webster University
| 4 years |
| Johannes Hermanus de Wit | M | 62 |
University of Utrecht
| 1 years |
| Heidi Hunter | F | 65 | 5 years | |
| Mark W. Bodmer | M | 69 | 4 years | |
| Marco Baptist Arie Keim | M | 62 |
University of Utrecht
| 3 years |
| Steven Lee Kiel | M | - |
Webster University
| 1 years |
| Gijs F. J. van Thiel | M | 57 |
Webster University
| 2 years |
| J. F. M. Westendorp | M | 68 |
University of Utrecht
| 3 years |
| Jack Elands | M | - |
University of Utrecht
| 4 years |
| Roberto Gradnik | M | 68 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 3 years |
| Steven M. Haag | M | - |
Webster University
| 4 years |
| Adrianus van Wijk | M | 68 |
University of Utrecht
| 4 years |
| Thomas G. Brackett | M | - |
Webster University
| 1 years |
| Leon Hooftman | M | - |
University of Utrecht
| 3 years |
| Robert Michael Kleine | M | 70 |
Webster University
| 1 years |
| Arthur Havener | M | 57 |
Webster University
| 2 years |
| Frederic Roch Doliveux | M | 68 | - | |
| Anna Richo | F | 63 | 7 years | |
| Frank Armstrong | M | 67 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 1 years |
| Kees van der Leun | M | - |
University of Utrecht
| 4 years |
| Lawrence Hillian | M | - |
Webster University
| 1 years |
| Zoltán Bûdy | M | 54 |
Webster University
| 4 years |
| Ken O'Neil | M | - |
Webster University
| 2 years |
| Deborah Brown | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 22 years |
| Mike Kazmierski | M | - |
Webster University
| 3 years |
| David McLaughlin | M | - |
Webster University
| 2 years |
| Howard Mayer | M | 61 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Lisa Buffington | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 5 years |
| Alexander Moscho | M | - | 3 years | |
| Huub den Rooijen | M | - |
University of Utrecht
| 4 years |
| Peter van Stiphout | M | - |
University of Utrecht
| 3 years |
| Marten Steen | M | 49 |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | 2 years |
| Maarten Antonius Johannes van den Belt | M | - |
University of Utrecht
| 4 years |
| Aalt Dijkhuizen | M | 70 |
University of Utrecht
| 3 years |
| Ismail Kola | M | 67 | 8 years | |
| Gerardus Wilhelmus van Odijk | M | 67 |
University of Utrecht
| 3 years |
| Jason G. Duncan | M | 50 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Jeff Gielen | M | 72 |
University of Utrecht
| 3 years |
| Jeff Miller | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 36 | 36.00% |
| Belgium | 26 | 26.00% |
| Netherlands | 23 | 23.00% |
| Luxembourg | 8 | 8.00% |
| Switzerland | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Bharat Tewarie
- Personal Network
